{"id":"W2128192445","doi":"10.1158/1078-0432.ccr-07-4619","title":"Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"Eli Lilly and Company; National Cancer Institute; Ludwig Institute for Cancer Research; Damon Runyon Cancer Research Foundation; Cancer Research Institute","keywords":"ELISPOT; Medicine; Internal medicine; Adverse effect; Vaccination; Immunology; Immunogenicity; Gastroenterology; Cancer; Ovarian cancer; Oncology; Antigen; Immune system; T cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005303543,0.000243675,0.0006481441,0.00007635821,0.0001679234,0.0001862886,0.0001634455,0.0003958113,0.0005620252],"category_scores_gemma":[0.0006549181,0.00009206278,0.0002816643,0.00007328314,0.0002111794,0.0002098881,0.0001143312,0.0006280479,0.00016337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002540161,"about_ca_system_score_gemma":0.0002493694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002243992,"about_ca_topic_score_gemma":0.0002494824,"domain_scores_codex":[0.9998223,0.00007543786,0.00001106735,0.00002847727,0.0000319752,0.00003076168],"domain_scores_gemma":[0.9995554,0.0001034239,0.0001442524,0.00004556596,0.00002935639,0.0001219903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2339976,0.03295561,0.1683752,0.0007440976,0.001206774,0.000837315,0.0007959812,0.003816882,0.2967442,0.0001796086,0.00134607,0.2590007],"study_design_scores_gemma":[0.01928031,0.699384,0.2374935,0.0000383596,0.0003615227,0.001306044,0.0001113642,0.002860036,0.03603234,0.00007154273,0.003044939,0.00001598144],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99937,0.0002935998,0.00009030827,0.00003235639,0.000007618885,0.00003705894,0.00001912903,0.000006919551,0.0001429324],"genre_scores_gemma":[0.9995437,0.0000845008,0.00006957677,0.00005617844,0.00001495219,0.00003180142,0.00006808498,0.000001454906,0.0001297424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006481441,"threshold_uncertainty_score":0.002804756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04623632557742297,"score_gpt":0.3742542925332915,"score_spread":0.3280179669558685,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}